B
oh and these
>>I know nothing about off-label use in the area of HIV, so I won't comment on that.
if ATC were approved in later-line/salvage, i imagine you could expect off label use to be a significant component of revenue...
>>Pricing isn't likely to be huge
as above i think there is some pretty clear guidance here, yeah, only $5-6k per patient per year with a lazy 100-150k pts... do the sums...
just need to clarify the path to market and some cash to get there...
but lets not get ahead of ourselves...
Something we all agree on...
I havent heard anyone support the old drongo...
DRONA MUST GO
VOTE NOW FOR ALL RESOLUTIONS
- Forums
- ASX - By Stock
- AVX
- prophetic article
prophetic article, page-34
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
MTL
Mantle Minerals' Nick Poll talks to HotCopper on finding gold grades up to 3.57g/t at Mt Berghaus